相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Treatment response to idelalisib in a patient with immunodeficiency-associated Burkitt lymphoma harboring a PIK3CA H1047R mutation
Annalen Bleckmann et al.
ANNALS OF HEMATOLOGY (2021)
BCR kinase inhibitors, idelalisib and ibrutinib, are active and effective in Richter syndrome
Andrea Visentin et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
Rapid and complete response to idelalisib in a case of Richter syndrome
Cristina Bagacean et al.
ONCOTARGETS AND THERAPY (2019)
The Role of PI3K Inhibition in Lymphoid Malignancies
Gottfried von Keudell et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2019)
Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes
Bjoern Chapuy et al.
NATURE MEDICINE (2018)
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
R. Schmitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Targeting B cell receptor signalling in cancer: preclinical and clinical advances
Jan A. Burger et al.
NATURE REVIEWS CANCER (2018)
Efficacy and safety of idelalisib in patients with relapsed, rituximab- and alkylating agent-refractory follicular lymphoma: a subgroup analysis of a phase 2 study
Gilles Salles et al.
HAEMATOLOGICA (2017)
Efficacy and safety of idelalisib in patients with relapsed, rituximab- and alkylating agent-refractory follicular lymphoma: a subgroup analysis of a phase 2 study
Gilles Salles et al.
HAEMATOLOGICA (2017)
Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma
Wyndham H. Wilson et al.
NATURE MEDICINE (2015)
The Genetic Landscape of Diffuse Large B-Cell Lymphoma
Laura Pasqualucci et al.
SEMINARS IN HEMATOLOGY (2015)
Discovery and saturation analysis of cancer genes across 21 tumour types
Michael S. Lawrence et al.
NATURE (2014)
PTEN loss defines a PI3K/AKT pathway-dependent germinal center subtype of diffuse large B-cell lymphoma
Matthias Pfeifer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
CP Hans et al.
BLOOD (2004)